SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConvaTec Regulatory News (CTEC)

Share Price Information for ConvaTec (CTEC)

Share Price is delayed by 15 minutes
Get Live Data
202.60    2.60 (1.30%)
Bid:
203.20
Ask:
203.60
Spread: 0.40 (0.197%)
Market Cap: £3.96b
CTEC Live PriceLast checked at - London Stock Exchange

Intraday ConvaTec Share Chart

AGM Corrected Poll Result

11 May 2018 15:27

RNS Number : 8674N
ConvaTec Group PLC
11 May 2018
 

 

Result of Meeting

 

 

CONVATEC GROUP PLC - AGM

11 MAY 2018 - CORRECTED POLL RESULT

 

ConvaTec Group Plc ("ConvaTec"), a leading global medical products and technologies company, held its annual general meeting today. The results of the poll held in relation to the resolutions proposed at the meeting are set out below. The number of votes withheld has been corrected and a column of number of votes cast included.

 

 

For (see note 2)

Against (see note 2)

Number of votes withheld (see note 3)

Number of votes cast

Total Capital Instructed

Resolution

No of shares

%

No of Shares

%

 

1

Receive Annual Report and Accounts

1,490,995,091

100.00

2,052

0.00

429,366

 

1,490,997,143

76.39%

2

Approve the Directors' Remuneration Report

1,457,090,861

98.33

24,766,857

1.67

 

9,568,789

 

1,481,857,718

75.92%

3

Declare Final Dividend

1,490,997,143

100.00

0

0.00

429,366

 

1,490,997,143

76.39%

4

Re-elect Sir Christopher Gent as a Director

1,483,108,674

99.47

7,885,399

0.53

432,436

 

1,490,994,073

76.39%

5

Re-elect Paul Moraviec as a Director

1,488,939,928

99.86

2,054,145

0.14

432,436

 

1,490,994,073

76.39%

6

Elect Frank Schulkes as a Director

1,481,688,827

99.38

9,305,246

0.62

 

432,436

 

1,490,994,073

76.39%

7

Re-elect Steve Holliday as a Director

1,482,717,535

99.44

8,277,540

0.56

431,434

 

1,490,995,075

76.39%

8

Re-elect Jesper Ovesen as a Director

1,476,891,196

99.05

14,102,877

0.95

432,436

 

1,490,994,073

76.39%

9

Re-elect Rick Anderson as a Director

1,488,985,560

99.87

2,009,487

0.13

 

431,462

 

1,490,995,047

76.39%

10

Re-elect Kasim Kutay as a Director

1,488,564,111

99.84

2,429,436

0.16

 

432,962

 

1,490,993,547

76.39%

11

Elect Ros Rivaz as a Director

1,486,522,754

99.70

4,471,319

0.30

 

432,436

 

1,490,994,073

76.39%

12

Elect Regina Benjamin as a Director

1,488,488,383

99.83

2,506,166

0.17

 

431,960

 

1,490,994,549

76.39%

13

Elect Margaret Ewing as a Director

1,488,980,460

99.86

2,014,587

0.14

 

431,462

 

1,490,995,047

76.39%

14

Re-appoint Deloitte LLP as auditors

1,490,989,671

100.00

6,418

0.00

 

430,420

 

1,490,996,089

76.39%

15

Authorise the Directors to agree the auditors' remuneration

1,490,994,110

100.00

3,033

0.00

 

 

429,366

 

 

1,490,997,143

76.39%

16

Authorise allotment of shares

1,479,661,716

99.25

11,131,674

0.75

 

633,119

 

1,490,793,390

76.38%

17

Disapply pre-emption rights*

1,490,781,972

99.99

213,817

0.01

 

430,720

 

1,490,995,789

76.39%

18

Disapply pre-emption rights in connection with an acquisition or specified capital investment*

1,428,938,102

95.84

62,052,586

4.16

 

 

 

435,820

 

 

 

1,490,990,688

76.39%

19

Authorise purchase of own shares*

1,485,284,913

99.75

3,698,352

0.25

 

2,443,243

 

1,488,983,265

76.29%

20

Authorise political donations and political expenditure

1,485,209,550

99.91

1,303,630

0.09

 

 

4,913,329

 

 

1,486,513,180

76.16%

21

Call general meetings on 14 days' notice*

1,442,987,025

97.07

43,526,671

2.93

4,912,813

 

1,486,513,696

76.16%

 

*Special Resolution

 

 

NOTES:

 

1. All resolutions were passed.

2. Votes "For" and "Against" are expressed as a percentage of votes received.

3. A "Vote withheld" is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution.

4. Total number of shares in issue at 6.30pm on 8 May 2018 was 1,951,850,599 shares. Up to 76.39% of voting capital was instructed.

 

 

 

 

 

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions. The Company is listed on the London Stock Exchange (stock symbol: CTEC) and has leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits, including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. www.convatecgroup.com

 

 

This information is provided by RNS

The company news service from the London Stock Exchange

 

Enquiries

 

Analysts and Investors

 

John Crosse, VP Investor Relations +44 (0)7500 141 435

Kirsty Law, Director Investor Relations +44 (0)7470 909 582

investorrelations@convatec.com

 

Media

 

Bobby Leach, VP Group Corporate Affairs +44 (0)7770 842 226

Finsbury +44 (0)207 251 3801 

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

# # #

END

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMSFDFLFFASEEI
Date   Source Headline
28th May 202611:00 amRNSHolding(s) in Company
27th May 202611:00 amRNSDirector/PDMR Shareholding
26th May 202611:00 amRNSHolding(s) in Company
21st May 20263:30 pmRNSResults of AGM
21st May 20267:00 amRNSAGM trading update for four months ended 30 April
13th Apr 202612:00 pmRNSProfessor Constantin Coussios steps down
9th Apr 20267:00 amRNSCapital Markets Day
17th Mar 20261:00 pmRNSNotice of AGM
17th Mar 202611:00 amRNSDirector/PDMR Shareholding
12th Mar 20262:30 pmRNSDirector/PDMR Shareholding
10th Mar 20261:00 pmRNSPublication of Annual Report
24th Feb 20267:00 amRNSConvatec FY25 Results
6th Feb 202611:00 amRNSHolding(s) in Company
2nd Jan 202611:00 amRNSTotal Voting Rights
19th Dec 202512:00 pmRNSHolding(s) in Company
19th Dec 202512:00 pmRNSHolding(s) in Company
17th Dec 20253:00 pmRNSHolding(s) in Company
10th Dec 20253:00 pmRNSHolding(s) in Company
4th Dec 20257:00 amRNSTransaction in Own Shares
3rd Dec 202512:00 pmRNSHolding(s) in Company
3rd Dec 20257:00 amRNSTransaction in Own Shares
2nd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 202511:00 amRNSTotal Voting Rights
1st Dec 20257:00 amRNSTransaction in Own Shares
28th Nov 20257:00 amRNSTransaction in Own Shares
27th Nov 20257:00 amRNSTransaction in Own Shares
26th Nov 20257:00 amRNSTransaction in Own Shares
25th Nov 202511:00 amRNSHolding(s) in Company
25th Nov 20257:00 amRNSTransaction in Own Shares
24th Nov 20255:05 pmRNSHolding(s) in Company
24th Nov 20255:00 pmRNSHolding(s) in Company
24th Nov 20257:00 amRNSTransaction in Own Shares
21st Nov 20255:30 pmRNSHolding(s) in Company
21st Nov 20257:00 amRNSTransaction in Own Shares
20th Nov 20251:30 pmRNSHolding(s) in Company
20th Nov 20257:00 amRNSTransaction in Own Shares
19th Nov 20257:00 amRNSTransaction in Own Shares
18th Nov 20256:00 pmRNSConvaTec Group
18th Nov 20257:00 amRNSPRICED SECONDARY OFFERING IN CONVATEC GROUP PLC
17th Nov 20254:57 pmRNSPROPOSED SECONDARY OFFERING IN CONVATEC GROUP PLC
14th Nov 20253:00 pmRNSHolding(s) in Company
13th Nov 20257:05 amRNSTransaction in Own Shares
13th Nov 20257:00 amRNSTrading update for 10 months ended 31 October 2025
12th Nov 20257:00 amRNSTransaction in Own Shares
11th Nov 20257:00 amRNSTransaction in Own Shares
10th Nov 20257:00 amRNSTransaction in Own Shares
7th Nov 20257:00 amRNSTransaction in Own Shares
6th Nov 20257:05 amRNSTransaction in Own Shares
6th Nov 20257:00 amRNSCEO and CFO appointments
5th Nov 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.